INTERNATIONAL PATENT: ALZECURE PHARMA AB FILES APPLICATION FOR "TRIAZINONE DERIVATIVES FOR USE IN THE TREATMENT OF INFLAMMATION"

GENEVA, Nov. 17 -- ALZECURE PHARMA AB (Halsovagen 7SE-141 57 Huddinge) filed a patent application (PCT/EP2024/074305) for "TRIAZINONE DERIVATIVES FOR USE IN THE TREATMENT OF INFLAMMATION" on Aug 30, 2024. With publication no. WO/2025/232990, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FORSELL, Pontus (AlzeCure Pharma ABHalsovagen 7SE- 141 57 Huddinge), SANDIN, Johan (AlzeCure Pharma ABHalsovagen 7SE- 141 57 Huddinge), PARRADO-FERNANDEZ, Cristina (AlzeCure Pharma ABHalsovagen 7SE- 141 57 Huddinge)

Abstract: There is p...